pI: 6.9268 |
Length (AA): 711 |
MW (Da): 82507 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
35 | 732 | 1qgr (A) | 134 | 807 | 11.00 | 0 | 1 | 0.946143 | 0.73 |
340 | 372 | 3bog (C) | 3 | 67 | 99.99 | 0 | 0 | 1.05989 | -0.25 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128955)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G48190 | serine/threonine-protein kinase ATM |
Brugia malayi | Bm1_40395 | Phosphatidylinositol 3- and 4-kinase family protein |
Candida albicans | CaO19.1018 | identical to the C terminus of CaP19.5580 potential phosphatidylinositol kinase |
Candida albicans | CaO19.5580 | similar to putative phosphatidylinositol kinase involved in telomere length regulation |
Candida albicans | CaO19.13026 | similar to putative phosphatidylinositol kinase involved in telomere length regulation |
Drosophila melanogaster | Dmel_CG6535 | telomere fusion |
Echinococcus granulosus | EgrG_000485500 | serine protein kinase ATM |
Entamoeba histolytica | EHI_017670 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000485500 | serine protein kinase ATM |
Homo sapiens | ENSG00000149311 | ATM serine/threonine kinase |
Leishmania braziliensis | LbrM.02.0130 | phosphatidylinositol kinase related protein, putative |
Leishmania donovani | LdBPK_020100.1 | phosphatidylinositol 3-kinase-like protein |
Leishmania infantum | LinJ.02.0100 | phosphatidylinositol kinase related protein, putative |
Leishmania major | LmjF.02.0120 | phosphatidylinositol kinase related protein, putative |
Leishmania mexicana | LmxM.02.0120 | phosphatidylinositol 3-kinase-like protein |
Loa Loa (eye worm) | LOAG_04206 | hypothetical protein |
Mus musculus | ENSMUSG00000034218 | ataxia telangiectasia mutated |
Neospora caninum | NCLIV_064490 | phosphatidylinositol 3- and 4-kinase domain- containing protein, putative |
Oryza sativa | 4326151 | Os01g0106700 |
Saccharomyces cerevisiae | YBL088C | Tel1p |
Schistosoma japonicum | Sjp_0026270 | hypothetical protein |
Schistosoma japonicum | Sjp_0308010 | IPR000971,Globin;IPR012292,Globin-related;IPR009050,Globin-like,domain-containing |
Schistosoma japonicum | Sjp_0065320 | ko:K04728 ataxia telangectasia mutated family protein, putative |
Schistosoma japonicum | Sjp_0108830 | hypothetical protein |
Schistosoma mansoni | Smp_157820 | ataxia telangiectasia mutated (atm) |
Schmidtea mediterranea | mk4.002177.01 | Serine/threonine-protein kinase ATM |
Schmidtea mediterranea | mk4.002177.02 | Serine-protein kinase ATM |
Trypanosoma brucei gambiense | Tbg.972.2.840 | phosphatidylinositol kinase domain protein, putative |
Trypanosoma brucei | Tb927.2.2260 | phosphatidylinositol kinase related protein, putative |
Trypanosoma cruzi | TcCLB.506533.34 | phosphatidylinositol kinase related protein, putative |
Trypanosoma cruzi | TcCLB.509395.20 | phosphatidylinositol kinase related protein, putative |
Trypanosoma cruzi | TcCLB.410961.10 | phosphatidylinositol kinase related protein, putative |
Toxoplasma gondii | TGME49_248530 | FATC domain-containing protein |
Trichomonas vaginalis | TVAG_139170 | PIKK family atypical protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.2.2260 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.2.2260 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.2.2260 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.2.2260 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_248530 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ATM serine/threonine kinase | Compounds | References |